Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Vickers

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
Clinical Trials (London, England)|February 14, 2022
Commentary on Aschmann et al: How do we incorporate harms in analyses of randomized trials?Andrew Vickers
BMJ (Clinical Research Ed.)|February 2, 2002
Widespread body pain and mortality. Theories that psychological states cause cancer should be rejectedAndrew Vickers
European Urology|June 28, 2011
Words of wisdom: Re: Population-based patterns and predictors of prostate-specific antigen screening among older men in the United StatesAndrew Vickers
European Urology|January 15, 2010
Prediction models in urology: are they any good, and how would we know anyway?Andrew Vickers
Evidence-Based Medicine|June 10, 2010
Dutasteride reduces incident prostate cancer in men after negative prostate biopsyAndrew Vickers
European Urology|September 4, 2013
Words of wisdom: Re: Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harmsAndrew Vickers
BJU International|January 30, 2023
Do not treat Bill Gates for prostate cancer! Algorithmic bias and causality in medical predictionAndrew Vickers
European Urology|July 4, 2012
Words of wisdom. Re: Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-upAndrew Vickers
CA: a Cancer Journal for Clinicians|April 6, 2004
Alternative cancer cures: "unproven" or "disproven"?Andrew Vickers
Nature Clinical Practice. Urology|October 11, 2007
How should we define patients who are at high risk of death from prostate cancer?Andrew Vickers
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
Clinical Trials (London, England)|February 14, 2022
Commentary on Aschmann et al: How do we incorporate harms in analyses of randomized trials?Andrew Vickers
BMJ (Clinical Research Ed.)|February 2, 2002
Widespread body pain and mortality. Theories that psychological states cause cancer should be rejectedAndrew Vickers
European Urology|June 28, 2011
Words of wisdom: Re: Population-based patterns and predictors of prostate-specific antigen screening among older men in the United StatesAndrew Vickers
European Urology|January 15, 2010
Prediction models in urology: are they any good, and how would we know anyway?Andrew Vickers
Evidence-Based Medicine|June 10, 2010
Dutasteride reduces incident prostate cancer in men after negative prostate biopsyAndrew Vickers
European Urology|September 4, 2013
Words of wisdom: Re: Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harmsAndrew Vickers
BJU International|January 30, 2023
Do not treat Bill Gates for prostate cancer! Algorithmic bias and causality in medical predictionAndrew Vickers
European Urology|July 4, 2012
Words of wisdom. Re: Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-upAndrew Vickers
CA: a Cancer Journal for Clinicians|April 6, 2004
Alternative cancer cures: "unproven" or "disproven"?Andrew Vickers
Nature Clinical Practice. Urology|October 11, 2007
How should we define patients who are at high risk of death from prostate cancer?Andrew Vickers
Pageof 23